home banner

Corporate website | Sitemap

References

1. Innocenti M, Moscatelli, G, Lopez, S. Efficacy of Gelclair in Reducing Pain in Patients with Oral Lesions: Preliminary Findings From an Open Pilot Study. Journal of Pain and Symptom Management 2002; 24(5):  456-457.

2. De Cordi, D, Martina, S. Gelclair: potentially an efficacious treatment for chemotherapy-induced mucositis. Presented at the Italian Tumour League III congress for professional oncology nurses, Conegliano, Italy, 10-12 October 2001.

3. Berndtson M. A Preliminary Study of Orassist (Gelclair) in the management of Oral Mucositis. This paper was published in Svensk Sjukhustandlakartidning (Swedish Hospital Dentistry) 2001 Nr 3 (Argang 26): 17-21.
 
4. Smith T, Gelclair: managing the symptoms of oral mucositis. Hospital Medicine,  2001;62 (10): 623-626.
 
5. Rubenstein E et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. American cancer soc.  2004: 2026-2046.
 
6. Sonis S et al. Oral Mucositis and the clinical and economic outcomes of hematopoietic stem –cell transplantation. J Clin Oncol. 2001; 19: 2201-2205.
 
7. Elting L et al.  The burdens of cancer therapy.  Cancer 2003; 98: 1531-1539
.

• Who can use Gelclair?

• What problems do oral lesions cause?

• How can Gelclair help?

• Further Information

• References

thorns



spaghetti

For further information on Gelclair please call Customer Services on 0191 2969300
or email customer.services@camb-labs.com